GIORGIONE, ROBERTA
 Distribuzione geografica
Continente #
EU - Europa 347
NA - Nord America 313
AS - Asia 96
AF - Africa 1
SA - Sud America 1
Totale 758
Nazione #
US - Stati Uniti d'America 313
RU - Federazione Russa 203
IE - Irlanda 52
IT - Italia 38
HK - Hong Kong 28
SG - Singapore 28
SE - Svezia 22
CN - Cina 16
JO - Giordania 15
CH - Svizzera 9
AT - Austria 8
IN - India 6
DE - Germania 5
FI - Finlandia 4
GB - Regno Unito 4
BE - Belgio 2
TW - Taiwan 2
BR - Brasile 1
CI - Costa d'Avorio 1
KR - Corea 1
Totale 758
Città #
Santa Clara 122
Dublin 52
Chandler 38
Singapore 22
Hong Kong 18
Ashburn 13
Florence 13
Bern 9
Fairfield 9
Milan 8
Moscow 8
Vienna 8
Altamura 6
Beijing 6
Lawrence 6
Pune 6
Ann Arbor 5
Boston 5
Bremen 5
Princeton 5
Boardman 4
Helsinki 4
San Diego 4
Kent 3
Seattle 3
Shanghai 3
Brussels 2
Los Angeles 2
Taichung 2
Tyumen 2
Abidjan 1
Almè 1
Buffalo 1
Hillsboro 1
Kilburn 1
London 1
Medford 1
Pisa 1
Prescot 1
Recanati 1
Seoul 1
São Paulo 1
Trumbull 1
Yubileyny 1
Totale 407
Nome #
Germline mutations in MSH2 and ATM gene in patients with GIST (gastrointestinal stromal tumor) and second epitelial tumors 97
Association of systemic steroid treatment and outcome in patients treated with immune checkpoint inhibitors: A real-world analysis 90
Occurrence of Dysgeusia in Patients Being Treated for Cancer 87
Active therapy or best supportive care after disease progression to both nivolumab and cabozantinib in metastatic renal cell carcinoma: The BEYOND study (Meet-Uro 19) 74
Beyond Conventional: The New Horizon of Targeted Therapy for the Treatment of Advanced Non Small Cell Lung Cancer 64
Analysis of molecular and clinical markers of resistance to bacillus of Calmette-Guérin immunotherapy in patients with urothelial non-muscle invasive bladder cancer 61
Castration-resistant prostate cancer with bone metastases: toward the best therapeutic choice 60
Association between Immune Related Adverse Events and Outcome in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors 56
Systemic Sclerosis Association with Malignancy 54
The emerging role of immunotherapy in biliary tract cancer: a review of new evidence and predictive biomarkers 51
Effect of systemic therapies or best supportive care after disease progression to both nivolumab and cabozantinib in metastatic renal cell carcinoma: The Meet-Uro 19BEYOND study 46
Darolutamide in hormone-sensitive and castration-resistant prostate cancer 44
Totale 784
Categoria #
all - tutte 3.882
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.882


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202245 0 0 0 0 0 0 0 16 6 2 4 17
2022/2023224 8 26 5 22 15 40 34 32 24 0 7 11
2023/2024122 4 15 13 3 11 19 8 23 2 9 6 9
2024/2025393 15 73 45 112 148 0 0 0 0 0 0 0
Totale 784